Showing results (41-50 of 1,889) with videos related to

Sort By:
Pageof 189
American Journal of Clinical Pathology|October 1, 1984
Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC)B Lämmle, T H Tran, R Ritz, et al.
Schweizerische Medizinische Wochenschrift|October 14, 1978
[Antibodies against various antigenic determinants in the factor VIII molecule (proceedings)]T Morger, B Marbet, G A Marbet, et al.
British Journal of Haematology|February 1, 1985
Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombinG Finazzi, T H Tran, T Barbui, et al.
European Heart Journal|December 1, 1992
Anticardiolipin antibodies and coronary heart diseaseD A Tsakiris, G A Marbet, F Burkart, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|September 1, 1992
Co-variation between biological markers and self-reported alcohol consumption. A two-year study of the relationship between changes in consumption and changes in the biological markers gamma-glutamyl transpeptidase (GGT) and average volume per erythrocyte (MCV) among problem drinkersF Duckert, J Johnsen, A Amundsen, et al.
Thrombosis and Haemostasis|April 25, 1989
The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT)S G Thompson, F Duckert, F Haverkate, et al.
Schweizerische Medizinische Wochenschrift|July 14, 1979
[Dissociation of human factor VIII and recombination of the fragments VIII-C and VIII-AG]T H Tran, H Bounameaux, G A Marbet, et al.
Thrombosis and Haemostasis|October 31, 1980
Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor XaT H Tran, C Bondeli, G A Marbet, et al.
Schweizerische Medizinische Wochenschrift|October 26, 1985
[Quantitative and qualitative hemostatic changes in 373 patients with recurring venous thromboses]G A Marbet, F Duckert, L Biland, et al.
Schweizerische Medizinische Wochenschrift|June 7, 1975
[Testing of the antirheumatic agent tolmetin for its interactions with oral anticoagulants]O Rüst, L Biland, D Thilo, et al.
Pageof 189